Fayyaz Akbar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fayyaz Akbar has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Aaron Quyn
Centre for Research into Cancer Prevention and Screening, University of Dundee, Dundee, UK
1 shared publication- Andrew Maw
Department of General Surgery, Glan Clwyd Hospital Rhyl, UK
1 shared publication Arnab Bhowmick
Department of General Surgery, Glan Clwyd Hospital, Rhyl LL18 5UJ
1 shared publication- Robert James Campbell Steele
Department of Surgery, Population Health and Genomics, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, Scotland, UK
1 shared publication
Latest Publications
- Open Access
- 1 May 2018
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 25 (4) , 178-182
Screening for colorectal cancer in defunctioned colons
Objectives: Population-based colorectal (bowel) cancer screening using faecal occult blood tests leads to a reduction in cause-specific mortality. However, in people where the colon is defunctioned, the use of standard faecal occult blood test is not appropriate. The aim of this study was to examine the current trends of clinical practice for colorectal cancer screening in people with defunctioned colons. Methods: An online survey was performed using SurveyMonkey. All members of the Association of Coloproctology of Great Britain and Ireland were invited by email to participate. Reminders were sent to non-responders and partial responders till six weeks. All responses were included in our analysis. Results: Of the 206 (34.59%) questionnaires completed, all questions were answered in 110 (55.8%). Among responders, 94 (85.4%) were colorectal consultant surgeons, 72% had worked in their current capacity for more than five years, and 105 (50.9%) had encountered colorectal cancer in defunctioned colons during their career. Some 72.2% of responders stated that a screening test for colorectal cancer in patients with defunctioned colons was currently not offered, or that they did not know whether or not it was offered in their area. Conclusions: Bowel screening in the United Kingdom is currently not offered to 72.2% of the age appropriate population with defunctioned colons. Among responding colorectal surgeons, 50% had encountered colorectal cancer in such patients. There is considerable variability in clinical practice regarding the optimal age for onset of screening, time interval, and the optimal modality to offer for screening in such cases.
- 1 May 2018
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 25 (4) , 178-182
Open AccessScreening for colorectal cancer in defunctioned colons
Objectives: Population-based colorectal (bowel) cancer screening using faecal occult blood tests leads to a reduction in cause-specific mortality. However, in people where the colon is defunctioned, the use of standard faecal occult blood test is not appropriate. The aim of this study was to examine the current trends of clinical practice for colorectal cancer screening in people with defunctioned colons. Methods: An online survey was performed using SurveyMonkey. All members of the Association of Coloproctology of Great Britain and Ireland were invited by email to participate. Reminders were sent to non-responders and partial responders till six weeks. All responses were included in our analysis. Results: Of the 206 (34.59%) questionnaires completed, all questions were answered in 110 (55.8%). Among responders, 94 (85.4%) were colorectal consultant surgeons, 72% had worked in their current capacity for more than five years, and 105 (50.9%) had encountered colorectal cancer in defunctioned colons during their career. Some 72.2% of responders stated that a screening test for colorectal cancer in patients with defunctioned colons was currently not offered, or that they did not know whether or not it was offered in their area. Conclusions: Bowel screening in the United Kingdom is currently not offered to 72.2% of the age appropriate population with defunctioned colons. Among responding colorectal surgeons, 50% had encountered colorectal cancer in such patients. There is considerable variability in clinical practice regarding the optimal age for onset of screening, time interval, and the optimal modality to offer for screening in such cases.
- Open Access
Anal ulceration induced by nicorandil
Case reportA 73 year old man was referred to our department with a one year history of rectal bleeding, mucus discharge, and anal pain. Associated conditions included diabetes mellitus, hypertension, hypercholesterolaemia, and severe ischaemic heart disease. Despite two previous coronary artery bypass operations, he continued to have angina. His medication included aspirin, atenolol, amlodipine, simvastatin, allopurinol, gliclazide, and 30 mg nicorandil twice a day.Initial assessment found a small posterior anal fissure and anal skin tags. For investigation of the bleeding, he underwent a rigid sigmoidoscopy and a barium enema, results of which were normal. We made a provisional diagnosis of an uncomplicated idiopathic anal fissure and started him on conservative treatment with topical analgesics and laxatives.His symptoms worsened, however, with increasing mucus discharge. Examination under anaesthesia showed normal rectal mucosa. There was a huge posterior anal fissure (2-3 cm wide) extending the entire length of the anal canal and another anterior fissure 1.0-1.5 cm wide with a flat base. The margins of the fissures were soft and non-indurated. We considered a diagnosis of Crohn's disease or malignancy, but histological examination of biopsy specimens from the lesion showed simple ulceration only.We changed the treatment to chemical sphincterotomy with topical application of diltiazem gel 2% for two months and concentrated on tight glycaemic control. Despite this, the ulceration progressed. Addition of glycerine trinitrate ointment 0.2% also failed, as did additional treatment with ciprofloxacin and metronidazole. We undertook further investigations to identify unusual causes of anal ulceration but results were negative, including those for HIV, syphilis, chlamydia, and lymphogranuloma venereum. Magnetic resonance imaging of the perianal region showed a suspected anal fistula associated with the fissure and so we undertook another examination under anaesthesia. We did not find a fistula, but the ulceration had deepened and enlarged to 2-3 cm wide and was eroding into intersphincteric plane (figs 1 and 2).⇓⇓View larger version: In this window In a new window Fig 1 Anterior fissureView larger version: In this window In a new window Fig 2 Posterior fissureAt this stage we became aware of reports of anal ulceration associated with nicorandil. After consultation with a cardiologist, we stopped the nicorandil and substituted it with isosorbide mononitrate. This resulted in the patient having an immediate episode of severe angina, but he recovered well. When the patient was reviewed in clinic two months later, his anal symptoms had improved considerably and the ulcer had reduced in size by 75%. Further healing continues.
Open AccessAnal ulceration induced by nicorandil
Case reportA 73 year old man was referred to our department with a one year history of rectal bleeding, mucus discharge, and anal pain. Associated conditions included diabetes mellitus, hypertension, hypercholesterolaemia, and severe ischaemic heart disease. Despite two previous coronary artery bypass operations, he continued to have angina. His medication included aspirin, atenolol, amlodipine, simvastatin, allopurinol, gliclazide, and 30 mg nicorandil twice a day.Initial assessment found a small posterior anal fissure and anal skin tags. For investigation of the bleeding, he underwent a rigid sigmoidoscopy and a barium enema, results of which were normal. We made a provisional diagnosis of an uncomplicated idiopathic anal fissure and started him on conservative treatment with topical analgesics and laxatives.His symptoms worsened, however, with increasing mucus discharge. Examination under anaesthesia showed normal rectal mucosa. There was a huge posterior anal fissure (2-3 cm wide) extending the entire length of the anal canal and another anterior fissure 1.0-1.5 cm wide with a flat base. The margins of the fissures were soft and non-indurated. We considered a diagnosis of Crohn's disease or malignancy, but histological examination of biopsy specimens from the lesion showed simple ulceration only.We changed the treatment to chemical sphincterotomy with topical application of diltiazem gel 2% for two months and concentrated on tight glycaemic control. Despite this, the ulceration progressed. Addition of glycerine trinitrate ointment 0.2% also failed, as did additional treatment with ciprofloxacin and metronidazole. We undertook further investigations to identify unusual causes of anal ulceration but results were negative, including those for HIV, syphilis, chlamydia, and lymphogranuloma venereum. Magnetic resonance imaging of the perianal region showed a suspected anal fistula associated with the fissure and so we undertook another examination under anaesthesia. We did not find a fistula, but the ulceration had deepened and enlarged to 2-3 cm wide and was eroding into intersphincteric plane (figs 1 and 2).⇓⇓View larger version: In this window In a new window Fig 1 Anterior fissureView larger version: In this window In a new window Fig 2 Posterior fissureAt this stage we became aware of reports of anal ulceration associated with nicorandil. After consultation with a cardiologist, we stopped the nicorandil and substituted it with isosorbide mononitrate. This resulted in the patient having an immediate episode of severe angina, but he recovered well. When the patient was reviewed in clinic two months later, his anal symptoms had improved considerably and the ulcer had reduced in size by 75%. Further healing continues.